About Us
Frisby Research is an independent biotech research platform focused on nanocap and small-cap healthcare companies.
We combine structured company tracking, catalyst monitoring, SEC filing review, clinical trial surveillance, and biology-aware analysis to help investors understand undercovered biotech opportunities and risks.
Public pages provide company snapshots and research previews, while private client areas support deeper research delivery, watchlists, alerts, and manually managed account access.
Frisby Research is for informational and educational purposes only and does not provide personalized investment advice.